Designing Precision Financing for cures can be informed by a framework that tailors solutions to the three financing challenges of actuarial risk, performance risk and payment timing based on the … Read More
The heterogeneity of health care payers suggests that durable therapies need precision financing targeted to each payer segment
FoCUS participants have identified four payer segments for precision financing: self-insured employers and related organizations; health insurance plans and managed care organizations; Medicare; and Medicaid. Download FoCUS Research Brief_2018F202-014Share the … Read More
Interview with Mark Trusheim for ADAPT SMART
Road MAPPs to therapeutic innovation One of the original thought leaders of the concept of Adaptive Pathways was the NEWDIGS initiative of MIT’s Center for Biomedical Innovation. ADAPT SMART has … Read More
Payers Open to Innovative Financing Mechanisms for High Cost Gene Therapies
In a broad survey, payers favor performance based milestone contracts and risk pools strategies to absorb the surge of high cost gene therapy products expected to enter the market over … Read More
MIT NEWDIGS Design Lab advances work on curative treatment financing strategies
Industry leaders, patient advocates, policymakers collaborate to make groundbreaking new therapies economically sustainable CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank” … Read More
MIT NEWDIGS Hosts Design Lab on New Gene and Oncology Therapy Financing Models
Industry leaders, patient advocates, policymakers collaborate to lower barriers to potentially curative treatments CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank” … Read More
NEWDIGS convenes healthcare leaders to pioneer new pharmaceutical financing strategies
CAMBRIDGE, Mass., Oct. 27, 2016 — Patient advocates, healthcare payers, industry, and academic stakeholders gathered today at the Massachusetts Institute of Technology (MIT) to map out a new strategy for … Read More
Mark Trusheim featured in Nature News Article: Financing Cures
Mark Trusheim, Director of NEWDIGS Strategic Initiatives, is quoted in the Nature News article “Promising gene therapies pose million-dollar conundrum“. He spoke at BIO on June 8th presenting on “Curative … Read More